phase 1_completion
saveAngel Pharmaceuticals Inc — soquelitinib (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Cutaneous T-Cell Lymphoma, Natural Killer Cell Lymphomas, Peripheral T-Cell Lymphomas (PTCL), T-Cell Leukemia, T-Cell Lymphomas
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that